The story has been corrected to say that certification from New York is for AssureRx's laboratory not its GeneSightRx test.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The New York State Department of Health has certified AssureRx's laboratory, allowing residents in the state access to the company's pharmacogenomic test, GeneSightRx.

As a result of the approval, the Mason, Ohio-based company's laboratory is certified to analyze DNA samples for pharmacogenomic testing in all 50 states.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.